Thrombocytosis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Line 497: | Line 497: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" |Condition | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition | ||
!Etiology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
!Decreased platelet production | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Decreased platelet production | ||
!Platelet destruction in blood | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Platelet destruction in blood | ||
!Platelet destruction in spleen | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Platelet destruction in spleen | ||
!Inherited | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inherited | ||
!Acquried | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried | ||
!Demography | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
!History | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History | ||
!Fever | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever | ||
!Rash | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rash | ||
!Bleeding | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding | ||
!BP | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP | ||
!Splenomegaly | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Splenomegaly | ||
!Jaundice | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Jaundice | ||
!Other signs | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other signs | ||
!Plt | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt | ||
!HB | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB | ||
!WBC | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC | ||
!PBS | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PBS | ||
!Bone marrow exam | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam | ||
!PT | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PT | ||
!PTT | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PTT | ||
!UA | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA | ||
!Imaging | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ||
!Gold standard | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
!Associated findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ||
|- | |- | ||
! rowspan="3" align="center" style="background:#DCDCDC;" + |Tissue damage | ! rowspan="3" align="center" style="background:#DCDCDC;" + |Tissue damage |
Revision as of 14:30, 28 August 2018
Thrombocytosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombocytosis differential diagnosis On the Web |
American Roentgen Ray Society Images of Thrombocytosis differential diagnosis |
Risk calculators and risk factors for Thrombocytosis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Thrombocytosis Differential Diagnosis
Differentiating the diseases that can cause thrombocytosis :
Category | Condition | Etiology | Mechanism | Inherited | Acquried | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | |||||||||||||||||||||||||
Lab Findings | Imaging | |||||||||||||||||||||||||||
Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other | CBC | PBS | Bone marrow exam | PT | PTT | UA | ||||||||||||||||
Increased megakaryocyte proliferation | Accelerated platelet release | Reduced platelet turnover | Plt | HB | WBC | |||||||||||||||||||||||
Autonomous thrombocytosis | Hematologic malignancies | Essential thrombocythemia | ||||||||||||||||||||||||||
Polycythemia vera | ||||||||||||||||||||||||||||
Primary myelofibrosis | ||||||||||||||||||||||||||||
Chronic myeloid leukemia | ||||||||||||||||||||||||||||
Myelodysplastic syndromes[1] |
|
+ | - | - | -/+ | + | Elderly | Exposure to | + | Petechiae, purpura, diffuse erythematous rash | + | Nl | + | + | Shortness of breath, fatigue | ↓ | ↓ | ↓ |
|
|
Nl | Nl | Nl | NA | Bone marrow examination + clinical manifestation |
| ||
Acute myeloid leukemia | ||||||||||||||||||||||||||||
Familial thrombocytosis | ||||||||||||||||||||||||||||
Category | Condition | Etiology | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Inherited | Acquried | Demography | History | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings | |
Reactive thrombocytosis | Anemia/
blood loss |
|
||||||||||||||||||||||||||
Infection | Chronic infections | |||||||||||||||||||||||||||
Tuberculosis | ||||||||||||||||||||||||||||
Acute bacterial and viral infections | ||||||||||||||||||||||||||||
Inflammation | Vasculitides | |||||||||||||||||||||||||||
Acute pancreatitis | ||||||||||||||||||||||||||||
Malignancy | ||||||||||||||||||||||||||||
Condition | Etiology | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Inherited | Acquried | Demography | History | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings | ||
Tissue damage | Thermal burns | |||||||||||||||||||||||||||
Trauma | ||||||||||||||||||||||||||||
Myocardial infarction | ||||||||||||||||||||||||||||
Medication | Myelosuppressive agents | |||||||||||||||||||||||||||
Vincristine | ||||||||||||||||||||||||||||
Epinephrine, glucocorticoids | ||||||||||||||||||||||||||||
Interleukin-1B | ||||||||||||||||||||||||||||
All-trans retinoic acid | ||||||||||||||||||||||||||||
Thrombopoietin | ||||||||||||||||||||||||||||
Other | Post-splenectomy or functional asplenia | |||||||||||||||||||||||||||
Allergic reactions | ||||||||||||||||||||||||||||
Exercise | ||||||||||||||||||||||||||||
Category | Condition | Etiology | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Inherited | Acquried | Demography | History | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings |
References
- ↑ Natelson, Ethan A.; Pyatt, David (2013). "Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog". Advances in Hematology. 2013: 1–11. doi:10.1155/2013/309637. ISSN 1687-9104.